Cargando…

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS

BACKGROUND: Several concepts of treatment in neonatal ARDS have been proposed in the last years. The present study compared the effects of open lung concept positive pressure ventilation (PPV(OLC)) with a conventional ventilation strategy combined with administration of two different surfactant prep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilgendorff, Anne, Aslan, Ece, Schaible, Thomas, Gortner, Ludwig, Baehner, Thorsten, Ebsen, Michael, Kreuder, Jochen, Ruppert, Clemens, Guenther, Andreas, Reiss, Irwin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483254/ https://www.ncbi.nlm.nih.gov/pubmed/18625067 http://dx.doi.org/10.1186/1471-2466-8-10

Ejemplares similares

Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced
por: Heidinger, Kathrin, et al.
Publicado: (2005)

Saline lavage with substitution of bovine surfactant in term neonates with meconium aspiration syndrome (MAS) transferred for extracorporeal membrane oxygenation (ECMO): a pilot study
por: Möller, Jens C, et al.
Publicado: (1999)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study
por: Möller, Jens Christian, et al.
Publicado: (2003)

Cardiopulmonary bypass and pulmonary surfactant: influence on composition and function?
por: Thul, J, et al.
Publicado: (2003)

Dry powder nebulization of a recombinant surfactant protein C-based surfactant for treatment of acute respiratory distress syndrome
por: Ruppert, C, et al.
Publicado: (2007)

Surfactant for the Treatment of ARDS in a Patient With COVID-19
por: Heching, Moshe, et al.
Publicado: (2021)

Reduced levels of pulmonary surfactant in COVID-19 ARDS
por: Schousboe, Peter, et al.
Publicado: (2022)

Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS
por: Qaqish, Robert, et al.
Publicado: (2020)

Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration
por: Schmidt, Reinhold, et al.
Publicado: (2007)

Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
por: De Luca, Daniele, et al.
Publicado: (2021)

Gene expression profiling at birth characterizing the preterm infant with early onset infection
por: Hilgendorff, Anne, et al.
Publicado: (2016)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Early decompressive craniectomy and duraplasty for refractory intracranial hypertension in children: results of a pilot study
por: Ruf, Bettina, et al.
Publicado: (2003)

Bronchopulmonary dysplasia - an overview about pathophysiologic concepts
por: Niedermaier, Sophie, et al.
Publicado: (2015)

Current Concepts of ARDS: A Narrative Review
por: Umbrello, Michele, et al.
Publicado: (2016)

Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Bhatt, Reena M, et al.
Publicado: (2021)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

Lipid profile modifications of the lung tissue and surfactant in a murine model of malaria associated ARDS
por: Scaccabarozzi, Diletta, et al.
Publicado: (2012)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
por: Kumar, Pradeep
Publicado: (2020)

Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
por: Piva, Simone, et al.
Publicado: (2021)

The Effects of Lung Protective Ventilation or Hypercapnic Acidosis on Gas Exchange and Lung Injury in Surfactant Deficient Rabbits
por: Hummler, Helmut D., et al.
Publicado: (2016)

Editorial: Bronchopulmonary Dysplasia: Past, Current and Future Pathophysiologic Concepts and Their Contribution to Understanding Lung Disease
por: Bush, Andrew, et al.
Publicado: (2022)

How to Perfuse: Concepts of Cerebral Protection during Arch Replacement
por: Habertheuer, Andreas, et al.
Publicado: (2015)

Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics—Model Development and Validation on ARDS and IPF Patients
Publicado: (2021)

Quality assessment and response to less invasive surfactant administration (LISA) without sedation
por: de Kort, Ellen, et al.
Publicado: (2019)

Simulation-based neonatal resuscitation training of medical students: is Peyton’s 4-stage approach more effective than traditional 2-stage technique?
por: Tutdibi, Erol, et al.
Publicado: (2014)

Modifying enzyme replacement therapy – A perspective
por: Schaible, Philipp
Publicado: (2022)

Allogeneic cord blood transfusions for extremely preterm neonates: an extremely promising proof of concept
por: Lopriore, Enrico, et al.
Publicado: (2020)

Comparison of mortality and short-term outcomes between classic, intubation-surfactant-extubation, and less invasive surfactant administration methods of surfactant replacement therapy
por: Kim, Seung Yeon, et al.
Publicado: (2023)

Mechanical ventilation-induced alterations of intracellular surfactant pool and blood–gas barrier in healthy and pre-injured lungs
por: Krischer, Jeanne-Marie, et al.
Publicado: (2020)

Contribution of HMSE-1 to surfactant conversion under acute inflammatory conditions
por: Ruppert, C, et al.
Publicado: (2007)

Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study
por: Keller, Roberta L., et al.
Publicado: (2012)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial
por: Fani, Kamal, et al.
Publicado: (2021)

Correlation of Surfactant Protein-D (SP-D) Serum Levels with ARDS Severity and Mortality in Covid-19 Patients in Indonesia
por: Agustama, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2js3cu5ukmu90pmbh5pda29ior